Company Number: 13192200

Analysis Date: 2025-07-29 20:07 UTC

1. Industry Classification
   Cosmox Aesthetics Ltd operates under SIC code 86900, classified as "Other human health activities." This sector broadly encompasses businesses involved in specialized health services that do not fall under mainstream healthcare categories such as hospitals or general medical practice. Typical activities can include aesthetic medicine, cosmetic treatments, and other ancillary health services. The sector often features a mix of small private clinics and service providers focused on elective procedures and wellness, with relatively high regulatory oversight and a strong emphasis on client trust and service quality.

2. Relative Performance
   Financially, Cosmox Aesthetics Ltd is a small private limited company with a single director controlling 75-100% of shares and voting rights. Its latest available accounts for the year ending March 2024 show:

• Negative net assets of approximately £31,974, indicating that liabilities exceed assets and the company is currently in a net liability position.
• Fixed assets valued at around £22,944, primarily tangible assets such as motor vehicles and fixtures and fittings.
• Cash reserves are modest at £5,916, with current liabilities exceeding £60,000, largely due to a director's loan account.
• The company has an increasing workforce, from 1 employee in 2023 to 8 in 2024, suggesting growth in operations or service capacity.

Compared to typical industry benchmarks in the aesthetic health sector, where many small practices maintain positive equity and manageable liabilities, Cosmox Aesthetics’ negative net asset position is a concern. However, early-stage businesses in this sector often exhibit initial losses due to capital investment and market development costs. The small scale and relatively low turnover (no turnover disclosed but inferred to be low given exemption filing) place it at the micro or small end of the sector spectrum.

3. Sector Trends Impact
   The aesthetics and specialized human health sector has experienced growth driven by rising consumer interest in elective cosmetic procedures, technological advancements (such as non-invasive treatments), and increased social acceptance. However, the sector is also sensitive to economic cycles; discretionary spending tends to reduce in downturns, which can impact revenue streams. Regulatory scrutiny and compliance costs have increased, requiring investment in quality assurance and staff training. The Covid-19 pandemic disrupted patient flows, but recovery is underway with renewed demand. For a small company like Cosmox Aesthetics, navigating these dynamics requires careful financial management and market positioning to capitalize on growth while controlling costs.

4. Competitive Positioning
   Strengths:

• Being a private limited company with a single controlling director allows for agile decision-making.
• The increase in employee numbers suggests scaling capabilities and potential service expansion.
• Tangible fixed assets indicate some investment in operational infrastructure.

Weaknesses:

• Negative net assets and reliance on director loans highlight financial vulnerability and potential liquidity risks.
• Small scale and limited capital may restrict marketing reach and competitive positioning against larger clinics or chains.
• Limited turnover disclosure constrains assessment of revenue performance relative to competitors.

Compared to more established competitors in the sector, which often have stronger balance sheets and diversified service offerings, Cosmox Aesthetics appears to be a niche player or an emerging entrant still building its market presence. Its financial structure suggests a need for stronger capitalization or external funding to support sustainable growth and improve solvency ratios.